TP53 and neoplasm: In particular, a decrease in the level of VEGF-A and MMP2 presented on the surface of EVs may be associated with a disruption of the functions of p53 as a tumor suppressor, which, in turn, affects matrix remodeling and the induction of angiogenesis.